Signature Bank And SigmaTron International On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Signature Bank, Cronos Group, and SunPower Corporation.

Rank Financial Asset Price Change Updated (EST)
1 Signature Bank (SBNY) 0.05 66.67% 2023-09-12 23:06:07
2 Cronos Group (CRON) 2.51 11.57% 2023-09-13 13:16:58
3 SunPower Corporation (SPWR) 7.29 10.12% 2023-09-13 06:23:06
4 Avidity Biosciences (RNA) 7.21 9.74% 2023-09-12 19:46:07
5 Pacific Biosciences of California (PACB) 11.68 8.5% 2023-09-13 13:14:50
6 Sage Therapeutics (SAGE) 23.44 8.27% 2023-09-12 21:12:07
7 Identiv (INVE) 8.74 7.24% 2023-09-13 13:13:47
8 Aware, Inc. (AWRE) 1.54 6.94% 2023-09-13 12:26:06
9 Sangamo Therapeutics (SGMO) 0.99 6.82% 2023-09-13 01:10:07
10 Sinclair Broadcast Group (SBGI) 11.81 6.78% 2023-09-12 22:44:07

The three biggest losers today are SigmaTron International, Aurora Cannabis, and Canopy Growth.

Rank Financial Asset Price Change Updated (EST)
1 SigmaTron International (SGMA) 3.54 -12.38% 2023-09-13 01:09:06
2 Aurora Cannabis (ACB) 0.84 -12.28% 2023-09-13 13:02:26
3 Canopy Growth (CGC) 1.23 -8.21% 2023-09-13 13:24:55
4 Surmodics (SRDX) 35.53 -7.11% 2023-09-13 07:09:06
5 3M Company (MMM) 100.80 -5.93% 2023-09-13 13:22:56
6 American Airlines (AAL) 13.28 -5.88% 2023-09-13 13:10:26
7 Apache (APA) 41.61 -5.86% 2023-09-13 13:16:32
8 Nikola (NKLA) 0.86 -5.77% 2023-09-13 13:17:48
9 Stratasys, Ltd. (SSYS) 12.48 -5.67% 2023-09-13 07:14:07
10 Trevena (TRVN) 0.68 -5.26% 2023-09-13 14:23:08

Winners today

1. Signature Bank (SBNY) – 66.67%

Signature Bank provides commercial banking products and services. It accepts various deposit products, including checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, certificates of deposit, and other cash management products. The company provides various lending products comprising commercial and industrial loans, real estate loans, and letters of credit. In addition, it offers asset management and investment products; and retirement products, such as individual retirement accounts and administrative services for retirement vehicles. Further, the company provides wealth management services to its high net worth personal clients; and purchases, sells, and assembles small business administration loans and pools. Additionally, it offers individual and group insurance products, including health, life, disability, and long-term care insurance products for business and private clients. As of December 31, 2021, the company operated 37 private client offices located in the metropolitan New York area, Connecticut, California, and North Carolina. Signature Bank was incorporated in 2000 and is headquartered in New York, New York.

NASDAQ ended the session with Signature Bank rising 66.67% to $0.05 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Signature Bank has a trailing twelve months EPS of $20.76.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.87%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14%, now sitting on 2.62B for the twelve trailing months.

More news about Signature Bank.

2. Cronos Group (CRON) – 11.57%

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

NASDAQ ended the session with Cronos Group rising 11.57% to $2.51 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Cronos Group has a trailing twelve months EPS of $-0.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.1%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 80% and 90.5%, respectively.

More news about Cronos Group.

3. SunPower Corporation (SPWR) – 10.12%

SunPower Corporation delivers solar solutions worldwide. It operates through Residential, Light Commercial; Commercial and Industrial Solutions; and Others segments. The company provides solar energy solutions, including sales to its third-party dealer network and resellers, storage solutions, cash and loan sales, and long-term leases directly to end customers; and sells turn-key engineering, procurement, and construction services, as well as sells energy under power purchase agreements. It also offers commercial roof, carport, and ground mounted systems; and post-installation operations and maintenance services. In addition, the company provides residential leasing program services, as well as sells inverters manufactured by third parties. The company also serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activités USA.

NASDAQ ended the session with SunPower Corporation rising 10.12% to $7.29 on Wednesday, following the last session’s upward trend. NASDAQ jumped 0.29% to $13,813.58, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, SunPower Corporation has a trailing twelve months EPS of $0.44.

PE Ratio

SunPower Corporation has a trailing twelve months price to earnings ratio of 16.57. Meaning, the purchaser of the share is investing $16.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.34%.

Volume

Today’s last reported volume for SunPower Corporation is 6610930 which is 7.35% above its average volume of 6158090.

Moving Average

SunPower Corporation’s value is way below its 50-day moving average of $8.67 and way below its 200-day moving average of $13.46.

More news about SunPower Corporation.

4. Avidity Biosciences (RNA) – 9.74%

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

NASDAQ ended the session with Avidity Biosciences jumping 9.74% to $7.21 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Avidity Biosciences has a trailing twelve months EPS of $-3.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.45%.

More news about Avidity Biosciences.

5. Pacific Biosciences of California (PACB) – 8.5%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California rising 8.5% to $11.68 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.29% to $13,813.58, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.22%.

Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $11.68 at 17:32 EST, way under its 52-week high of $14.55 and way above its 52-week low of $4.97.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.28%, a negative 0.59%, and a positive 2.57%.

Pacific Biosciences of California’s highest amplitude of average volatility was 2.28% (last week), 2.43% (last month), and 2.57% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Pacific Biosciences of California’s EBITDA is 18.55.

More news about Pacific Biosciences of California.

6. Sage Therapeutics (SAGE) – 8.27%

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment resistant disorders, generalized anxiety disorders, and bipolar depression; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Sage Therapeutics jumping 8.27% to $23.44 on Wednesday while NASDAQ jumped 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Sage Therapeutics has a trailing twelve months EPS of $-10.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.55%.

More news about Sage Therapeutics.

7. Identiv (INVE) – 7.24%

Identiv, Inc. operates as a security technology company that secures things, data, and physical places in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Identity and Premises. The Identity segment offers products and solutions that enables secure access to information serving the logical access and cyber security markets, as well as protecting connected objects and information using radio-frequency identification embedded security. The Premises segment provides solutions for premises security market, such as access control, video surveillance, analytics, audio, access readers, and identities to government facilities, schools, utilities, hospitals, stores, and apartment buildings. The company sells its products through dealers, systems integrators, value added resellers, and resellers. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California.

NASDAQ ended the session with Identiv rising 7.24% to $8.74 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Identiv has a trailing twelve months EPS of $-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.07%.

Moving Average

Identiv’s worth is above its 50-day moving average of $8.30 and way above its 200-day moving average of $7.48.

More news about Identiv.

8. Aware, Inc. (AWRE) – 6.94%

Aware, Inc., a authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, Brazil, the United Kingdom, and internationally. The company offers biometric software solution, which includes Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification. It also provides BioSP, a service-oriented platform enables biometric system with advanced biometric data processing and management in a web services architecture; WebEnroll, a browser-based biometric enrollment and data management solution; and AwareID, an adaptive authentication platform provides biometric face and voice analysis, and document validation for cloud-based biometric application programming interfaces and turnkey services. In addition, the company offers biometrics applications, such as Nexa line, a biometric search and match SDKs including Nexa Fingerprint, Nexa Face, Nexa Iris, and Nexa Voice; and AwareXM, an interoperable fingerprint matching SDK that provides fingerprint minutiae extraction, template generation, and fingerprint authentication. Further, it sells imaging products used in medical and advanced imaging application; offers program management and software engineering services, and software maintenance services. The company sells its products, services, and solutions through systems integrators, direct, and original equipment manufacturers and value added resellers channel Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

NASDAQ ended the session with Aware, Inc. rising 6.94% to $1.54 on Wednesday while NASDAQ jumped 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Aware, Inc. has a trailing twelve months EPS of $-0.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.86%.

Volatility

Aware, Inc.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.46%, a negative 0.42%, and a positive 2.22%.

Aware, Inc.’s highest amplitude of average volatility was 3.24% (last week), 1.93% (last month), and 2.22% (last quarter).

More news about Aware, Inc..

9. Sangamo Therapeutics (SGMO) – 6.82%

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.

NASDAQ ended the session with Sangamo Therapeutics jumping 6.82% to $0.99 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Sangamo Therapeutics has a trailing twelve months EPS of $-1.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.93%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 5.9% and 18.8%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Sangamo Therapeutics’s EBITDA is 0.32.

Sales Growth

Sangamo Therapeutics’s sales growth is negative 64.8% for the current quarter and negative 69.3% for the next.

More news about Sangamo Therapeutics.

10. Sinclair Broadcast Group (SBGI) – 6.78%

Sinclair Broadcast Group, Inc. operates as a media company in the United States. The company operates in two segments, Broadcast and Local Sports. The Broadcast segment broadcasts free over-the-air programming, such as network provided programs, locally-produced news, local sporting events, programming from program service arrangements, syndicated entertainment programs, and programming to television viewing audiences in the communities through its local television stations. As of December 31, 2021, the segment owned, operated, and provided services to 185 stations and 634 channels in 86 markets. The Local Sports segment operates regional sports networks. This segment broadcasts professional sports games and produce content. In addition, this segment owns regional sports network, which has the rights to air games of 45 professional sports teams and other sporting events. The company also owns and operates Tennis Channel, a cable network, which includes coverage of various tennis' top tournaments and original professional sports and tennis lifestyle shows; the Tennis Channel International streaming service; Tennis Magazine, the sport's print publication; and Tennis.com, an online tennis platform. Further, it owns and operates various networks carried on distribution platforms, including Comet, a science fiction network; CHARGE!, an adventure and action-based network; TBD, a multiscreen TV network; Stadium, a professional sports highlights and college games network; STIRR, an ad-supported DTC streaming app; and NewsON, an ad-supported app that provides access to live or on-demand local news broadcasts, including non-Sinclair affiliate partners. Additionally, the company provides technical services to the broadcast industry; and owns various non-media related investments, such as private equity, mezzanine financing, and real estate investments. Sinclair Broadcast Group, Inc. was founded in 1986 and is headquartered in Hunt Valley, Maryland.

NASDAQ ended the session with Sinclair Broadcast Group rising 6.78% to $11.81 on Wednesday, after three successive sessions in a row of gains. NASDAQ jumped 0.29% to $13,813.58, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Sinclair Broadcast Group has a trailing twelve months EPS of $2.97.

PE Ratio

Sinclair Broadcast Group has a trailing twelve months price to earnings ratio of 3.98. Meaning, the purchaser of the share is investing $3.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.8%.

Moving Average

Sinclair Broadcast Group’s worth is way under its 50-day moving average of $13.23 and way below its 200-day moving average of $15.98.

More news about Sinclair Broadcast Group.

Losers Today

1. SigmaTron International (SGMA) – -12.38%

SigmaTron International, Inc. operates as an independent provider of electronic manufacturing services (EMS). Its EMS services include printed circuit board assemblies and completely assembled (box-build) electronic products. The company also offers automatic and manual assembly and testing of products; material sourcing and procurement services; manufacturing and test engineering support services; design services; warehousing and distribution services; and assistance in obtaining product approval from governmental and other regulatory bodies. In addition, the company offers electronic and electromechanical manufacturing solutions. It primarily serves industrial electronics, consumer electronics, and medical/life sciences industries in the United States, Mexico, China, Vietnam, and Taiwan. The company markets its services through independent manufacturers' representative organizations. SigmaTron International, Inc. was incorporated in 1993 and is headquartered in Elk Grove Village, Illinois.

NASDAQ ended the session with SigmaTron International falling 12.38% to $3.54 on Wednesday, after four consecutive sessions in a row of losses. NASDAQ jumped 0.29% to $13,813.58, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, SigmaTron International has a trailing twelve months EPS of $2.33.

PE Ratio

SigmaTron International has a trailing twelve months price to earnings ratio of 1.52. Meaning, the purchaser of the share is investing $1.52 for every dollar of annual earnings.

More news about SigmaTron International.

2. Aurora Cannabis (ACB) – -12.28%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.

NYSE ended the session with Aurora Cannabis sliding 12.28% to $0.84 on Wednesday, after five sequential sessions in a row of gains. NYSE dropped 0.17% to $15,926.64, after three consecutive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-10.54.

Volume

Today’s last reported volume for Aurora Cannabis is 103574000 which is 733.03% above its average volume of 12433300.

Volatility

Aurora Cannabis’s last week, last month’s, and last quarter’s current intraday variation average was 28.03%, 3.72%, and 4.29%.

Aurora Cannabis’s highest amplitude of average volatility was 29.91% (last week), 6.79% (last month), and 4.29% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aurora Cannabis’s stock is considered to be oversold (<=20).

More news about Aurora Cannabis.

3. Canopy Growth (CGC) – -8.21%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth dropping 8.21% to $1.23 on Wednesday, after two sequential sessions in a row of losses. NASDAQ jumped 0.29% to $13,813.58, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

: canopy growth stock continues slide after big runupIn regular trading on Tuesday, Canopy Growth stock fell nearly 21% after big runups in recent sessions after the U.S. Drug Enforcement Agency said on Aug. 30 it would review the Schedule I classification of cannabis. , Even with the loss, Canopy Growth stock is still up about 67% in the past five days.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-3.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.

Moving Average

Canopy Growth’s worth is way above its 50-day moving average of $0.49 and way below its 200-day moving average of $1.82.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canopy Growth’s stock is considered to be oversold (<=20).

More news about Canopy Growth.

4. Surmodics (SRDX) – -7.11%

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

NASDAQ ended the session with Surmodics sliding 7.11% to $35.53 on Wednesday while NASDAQ jumped 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Surmodics has a trailing twelve months EPS of $-1.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.33%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 169.2% and 18%, respectively.

Yearly Top and Bottom Value

Surmodics’s stock is valued at $35.53 at 17:32 EST, under its 52-week high of $39.41 and way above its 52-week low of $16.00.

Sales Growth

Surmodics’s sales growth for the current quarter is 1.1%.

More news about Surmodics.

5. 3M Company (MMM) – -5.93%

3M Company provides diversified technology services in the United States and internationally. The company operates through four segments: Safety and Industrial; Transportation and Electronics; Health Care; and Consumer. The Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. The Transportation and Electronics segment provides ceramic solutions; attachment tapes, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; and reflective signage for highway, and vehicle safety. The Healthcare segment offers health care procedure coding and reimbursement software; skin, wound care, and infection prevention products and solutions; dentistry and orthodontia solutions; and filtration and purification systems. The Consumer segment provides consumer bandages, braces, supports, and consumer respirators; cleaning products for the home; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in St. Paul, Minnesota.

NYSE ended the session with 3M Company sliding 5.93% to $100.80 on Wednesday while NYSE fell 0.17% to $15,926.64.

Earnings Per Share

As for profitability, 3M Company has a trailing twelve months EPS of $-2.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.37%.

Volume

Today’s last reported volume for 3M Company is 4344620 which is 20.02% above its average volume of 3619770.

More news about 3M Company.

6. American Airlines (AAL) – -5.88%

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. As of December 31, 2022, it operated a mainline fleet of 925 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.

NASDAQ ended the session with American Airlines sliding 5.88% to $13.28 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

: American Airlines stock drops after profit outlook cut, citing higher fuel costs and a $230 million labor expenseShares of American Airlines Group Inc. dropped toward a four-month low Wednesday after the air carrier cut its third-quarter earnings outlook, citing higher fuel prices and costs associated with a new labor agreement.

Earnings Per Share

As for profitability, American Airlines has a trailing twelve months EPS of $3.91.

PE Ratio

American Airlines has a trailing twelve months price to earnings ratio of 3.4. Meaning, the purchaser of the share is investing $3.4 for every dollar of annual earnings.

Volatility

American Airlines’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.57%, a negative 0.53%, and a positive 1.33%.

American Airlines’s highest amplitude of average volatility was 1.10% (last week), 1.08% (last month), and 1.33% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

American Airlines’s EBITDA is 0.75.

More news about American Airlines.

7. Apache (APA) – -5.86%

APA Corporation, through its subsidiaries, explores for, develops, and produces natural gas, crude oil, and natural gas liquids. It has operations in the United States, Egypt, and the United Kingdom, as well as has exploration activities offshore Suriname. The company also operates gathering, compression, processing, and transmission assets in West Texas, as well as holds ownership in four Permian Basin long-haul pipeline. APA Corporation was founded in 1954 and is based in Houston, Texas.

NASDAQ ended the session with Apache sliding 5.86% to $41.61 on Wednesday while NASDAQ jumped 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Apache has a trailing twelve months EPS of $4.88.

PE Ratio

Apache has a trailing twelve months price to earnings ratio of 8.53. Meaning, the purchaser of the share is investing $8.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 116.03%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Apache’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for Apache is 7511670 which is 70.95% above its average volume of 4393920.

Moving Average

Apache’s value is higher than its 50-day moving average of $38.71 and above its 200-day moving average of $39.58.

More news about Apache.

8. Nikola (NKLA) – -5.77%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola dropping 5.77% to $0.86 on Wednesday while NASDAQ jumped 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -132.55%.

More news about Nikola.

9. Stratasys, Ltd. (SSYS) – -5.67%

Stratasys Ltd. provides connected and polymer-based 3D printing solutions. It offers 3D printing systems, such as polyjet printers, FDM printers, stereolithography printing systems, and programmable photo polymerization printers for rapid prototyping, such as design validation, visualization, and communication. The company also provides 3D printing materials, including approximately FDM spool-based filament materials, polyjet cartridge-based resin materials, non-color digital materials, and color variations for use in 3D printers and production systems. In addition, it offers GrabCAD Print Platform that offers job programming, scheduling, monitoring, order management, and analytics across various 3D printing technologies. Further, the company operates Thingiverse.com, an online community for sharing downloadable and digital 3D designs; and GrabCAD Community for mechanical engineers, designers, manufacturers, and students. Its products and services are primarily used in the automotive, aerospace, medical, dental, education, and consumer goods markets. The company sells its products through a network of resellers and independent sales agents worldwide. Stratasys Ltd. was incorporated in 1989 and is headquartered in Eden Prairie, Minnesota.

NASDAQ ended the session with Stratasys, Ltd. falling 5.67% to $12.48 on Wednesday while NASDAQ rose 0.29% to $13,813.58.

Earnings Per Share

As for profitability, Stratasys, Ltd. has a trailing twelve months EPS of $-0.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.82%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Stratasys, Ltd.’s EBITDA is 1.07.

Volume

Today’s last reported volume for Stratasys, Ltd. is 1580140 which is 50.68% above its average volume of 1048670.

More news about Stratasys, Ltd..

10. Trevena (TRVN) – -5.26%

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

NASDAQ ended the session with Trevena sliding 5.26% to $0.68 on Wednesday, after two sequential sessions in a row of losses. NASDAQ rose 0.29% to $13,813.58, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Trevena has a trailing twelve months EPS of $-3.87.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -166.79%.

Yearly Top and Bottom Value

Trevena’s stock is valued at $0.68 at 17:32 EST, way below its 52-week high of $5.48 and way above its 52-week low of $0.54.

More news about Trevena.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *